These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23520056)

  • 1. Surface modification of implanted cardiovascular metal stents: from antithrombosis and antirestenosis to endothelialization.
    Zhang K; Liu T; Li JA; Chen JY; Wang J; Huang N
    J Biomed Mater Res A; 2014 Feb; 102(2):588-609. PubMed ID: 23520056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Programmable elution profile coating for drug eluting stents.
    Al-Lamee K
    Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drug-eluting stent platforms to prevent stent thrombosis.
    Kereiakes DJ
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S34-43. PubMed ID: 17401310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
    Waksman R; Pakala R
    EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo biocompatibility of a plasma-activated, coronary stent coating.
    Waterhouse A; Wise SG; Yin Y; Wu B; James B; Zreiqat H; McKenzie DR; Bao S; Weiss AS; Ng MK; Bilek MM
    Biomaterials; 2012 Nov; 33(32):7984-92. PubMed ID: 22889486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xience V everolimus-eluting coronary stent.
    Kukreja N; Onuma Y; Serruys PW
    Expert Rev Med Devices; 2009 May; 6(3):219-29. PubMed ID: 19419279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
    Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
    Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery model.
    Lysitsas DN; Katsouras CS; Papakostas JC; Toumpoulis IK; Angelidis C; Bozidis P; Thomas CG; Seferiadis K; Psychoyios N; Frillingos S; Pavlidis N; Marinos E; Khaldi L; Sideris DA; Michalis LK
    Cardiovasc Intervent Radiol; 2007; 30(6):1192-200. PubMed ID: 17828426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of stent design and coatings on restenosis and thrombosis.
    Hara H; Nakamura M; Palmaz JC; Schwartz RS
    Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomaterial testing for covered stent membranes: evaluating thrombosis and restenosis potential.
    Weaver JD; Ku DN
    J Biomed Mater Res B Appl Biomater; 2012 Jan; 100(1):103-10. PubMed ID: 21954071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency, etiology, treatment, and outcomes of drug-eluting stent thrombosis during one year of follow-up.
    Sandhu G; Doyle B; Singh R; Bell M; Bresnahan J; Mathew V; Holmes D; Lerman A; Rihal C
    Am J Cardiol; 2007 Feb; 99(4):465-9. PubMed ID: 17293185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface modification of coronary stents with SiCOH plasma nanocoatings for improving endothelialization and anticoagulation.
    Zhang Q; Shen Y; Tang C; Wu X; Yu Q; Wang G
    J Biomed Mater Res B Appl Biomater; 2015 Feb; 103(2):464-72. PubMed ID: 24919787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The (PrS/HGF-pDNA) multilayer films for gene-eluting stent coating: Gene-protecting, anticoagulation, antibacterial properties, and in vivo antirestenosis evaluation.
    Chang H; Ren KF; Zhang H; Wang JL; Wang BL; Ji J
    J Biomed Mater Res B Appl Biomater; 2015 Feb; 103(2):430-9. PubMed ID: 24909849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
    Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.